Delivery Order SPE2DB24D2010-SPE2DB26FZRY7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) valued at $1,122.42. This competitively awarded, firm fixed-price delivery order is expected to be completed by October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract does not utilize a set-aside designation and represents a child delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) with a ceiling value of $3,829.24. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of dextroamphetamine-amphetamine 10 mg capsules (100-count) with a ceiling value of $1,095.15. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) valued at $1,868.16. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count containers) with a ceiling value of $4,218.80. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for dextroamphetamine-amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,597.36. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is set to complete by July 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,346.64 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg capsules (100 count) on October 16, 2025, with an ultimate completion date of October 17, 2025. This is a firm fixed-price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) with a ceiling value of $2,675.76. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will...
- The Defense Logistics Agency awarded a $4,713.03 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of dextroamphetamine-amphetamine 10 mg capsules (100-count). The contract, designated as a firm fixed-price delivery order with no set-aside, has an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a ceiling value of $2,139.28. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025. The award utilized no set-aside designation and was competitively awarded through an open procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB26FZRY7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) valued at $2,995.89. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is to be completed by October 23, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999 million and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves the Defense Health Agency and military healthcare systems through its comprehensive pharmaceutical supply portfolio. The parent IDC represents a global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. This particular delivery order for controlled amphetamine medication supports the Department of Defense's pharmaceutical supply chain requirements, with the company regularly fulfilling such competitively awarded orders across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 10/22/25 |